IP Stock Analysis: International Paper | NYSE
Packaging & Containers | NYSE, USA | Market Cap: 20.281m USD | 12M Return: -14.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 221M
Qual. Beats: 0
Rev. Trend: 77.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
International Paper Company (NYSE: IP) is a global producer of renewable fiber-based packaging, operating across North America, Latin America, Europe, South America, and North Africa. The company runs through two reportable segments: Packaging Solutions North America and Packaging Solutions EMEA. Its product portfolio includes linerboard, medium, whitetop, and saturating kraft, which the company converts into corrugated boxes, bulk bins, shipping containers, and specialty packaging at its converting facilities. End markets span food and beverage, agriculture, industrial manufacturing, personal care, pharmaceuticals, and consumer goods. International Paper was founded in 1898 and is headquartered in Memphis, Tennessee. It is classified in the Materials sector under the GICS sub-industry of Paper & Plastic Packaging Products & Materials.
The company sits within the containerboard and corrugated packaging segment of the materials industry, whose output is widely recyclable and tied to broader supply chain, e-commerce, and industrial shipping demand. Large integrated producers like International Paper typically combine pulp and paper mills with downstream converting operations to capture additional margin beyond the sale of base containerboard.
- DS Smith acquisition synergy capture drives margin expansion
- Containerboard pricing pressured by demand normalization and new capacity
- Capital returns resume as leverage declines post DS Smith integration
| Net Income: -3.35b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.53 > 1.0 |
| NWC/Revenue: 6.04% < 20% (prev 11.56%; Δ -5.52% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.60b > Net Income -3.35b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (531.8m) vs 12m ago 21.53% < -2% |
| Gross Margin: 27.83% > 18% (prev 28.59%; Δ -0.77% > 0.5%) |
| Asset Turnover: 64.34% > 50% (prev 48.34%; Δ 16.00% > 0%) |
| Interest Coverage Ratio: -7.56 > 6 (EBIT TTM -2.81b / Interest Expense TTM 371.0m) |
| A: 0.04 (Total Current Assets 8.58b - Total Current Liabilities 7.07b) / Total Assets 36.4b |
| B: 0.13 (Retained Earnings 4.70b / Total Assets 36.4b) |
| C: -0.07 (EBIT TTM -2.81b / Avg Total Assets 38.8b) |
| D: 0.68 (Book Value of Equity 14.8b / Total Liabilities 21.6b) |
| Altman-Z'' = 0.92 = BB |
| DSRI: 0.75 (Receivables 4.69b/5.01b, Revenue 25.0b/19.9b) |
| GMI: 1.03 (GM 28.59% / 27.83%) |
| AQI: 0.97 (AQ_t 0.36 / AQ_t-1 0.37) |
| SGI: 1.25 (Revenue 25.0b / 19.9b) |
| TATA: -0.16 (NI -3.35b - CFO 2.60b) / TA 36.4b) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of July 01, 2026, the stock is trading at USD 38.10 with a total of 2,866,774 shares traded. Over the past week, the price has changed by +4.21%, over one month by +13.09%, over three months by +8.31% and over the past year by -14.75%.
Current recommended Stop Loss: 36.10 (which is 5.2% or 1.4 ATR below the current price).
International Paper has received a consensus analysts rating of 3.69. Therefore, it is recommended to hold IP.
- StrongBuy: 5
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 39.4 | 3.3% |
P/E Forward = 26.0417
P/S = 0.8332
P/B = 1.3696
P/EG = 1.5804
Revenue TTM = 25.0b USD
EBIT TTM = -2.81b USD
EBITDA TTM = -41.0m USD
Long Term Debt = 8.18b USD (from longTermDebt, last quarter)
Short Term Debt = 918.0m USD (from shortTermDebt, last quarter)
Debt = 9.99b USD (from shortLongTermDebtTotal, last quarter) + Leases 450.0m
Net Debt = 8.76b USD (calculated: Debt 9.99b - CCE 1.24b)
Enterprise Value = 29.0b USD (20.3b + Debt 9.99b - CCE 1.24b)
Interest Coverage Ratio = -7.56 (Ebit TTM -2.81b / Interest Expense TTM 371.0m)
EV/FCF = 52.51x (Enterprise Value 29.0b / FCF TTM 553.0m)
FCF Yield = 1.90% (FCF TTM 553.0m / Enterprise Value 29.0b)
FCF Margin = 2.22% (FCF TTM 553.0m / Revenue TTM 25.0b)
Net Margin = -13.42% (Net Income TTM -3.35b / Revenue TTM 25.0b)
Gross Margin = 27.83% ((Revenue TTM 25.0b - Cost of Revenue TTM 18.0b) / Revenue TTM)
Gross Margin QoQ = 20.73% (prev 31.35%)
Tobins Q-Ratio = 0.80 (Enterprise Value 29.0b / Total Assets 36.4b)
Interest Expense / Debt = 3.71% (Interest Expense 371.0m / Debt 9.99b)
Taxrate = 18.28% (17.0m / 93.0m)
NOPAT = -2.29b (EBIT -2.81b * (1 - 18.28%)) [loss with tax shield]
Current Ratio = 1.21 (Total Current Assets 8.58b / Total Current Liabilities 7.07b)
Debt / Equity = 0.67 (Debt 9.99b / totalStockholderEquity, last quarter 14.8b)
Debt / EBITDA = -213.6 (out of range, set to none) (Net Debt 8.76b / EBITDA -41.0m)
Debt / FCF = 15.84 (Net Debt 8.76b / FCF TTM 553.0m)
Total Stockholder Equity = 16.4b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.64% (Net Income -3.35b / Total Assets 36.4b)
RoE = -20.44% (Net Income TTM -3.35b / Total Stockholder Equity 16.4b)
RoCE = -11.42% (EBIT -2.81b / Capital Employed (Equity 16.4b + L.T.Debt 8.18b))
RoIC = -7.90% (negative operating profit) (NOPAT -2.29b / Invested Capital 29.0b)
WACC = 7.58% (E(20.3b)/V(30.3b) * Re(9.82%) + D(9.99b)/V(30.3b) * Rd(3.71%) * (1-Tc(0.18)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 71.91 | Cagr: 21.00%
[DCF] Terminal Value 75.44% ; FCFF base≈553.0m ; Y1≈555.3m ; Y5≈588.2m
[DCF] Fair Price = 0.74 (EV 9.15b - Net Debt 8.76b = Equity 391.7m / Shares 529.5m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.03 | # QB: 0
Revenue Correlation: 77.09 | Revenue CAGR: 10.44% | SUE: -0.16 | # QB: 0
EPS next Quarter (2026-09-30): EPS=0.53 | Chg30d=-6.42% | Revisions=-54% | Analysts=9
EPS current Year (2026-12-31): EPS=1.38 | Chg30d=+0.73% | Revisions=-71% | GrowthEPS=+789.9% | GrowthRev=+4.5%
EPS next Year (2027-12-31): EPS=2.67 | Chg30d=-0.22% | Revisions=-29% | GrowthEPS=+93.6% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: -71%